Loading
Latest filing published 21 Mar 2014 for CADENCE PHARMACEUTICALS INC, €100k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Todd W. Rich on record concern Cadence Pharmaceuticals Inc. In total, 2 filings cover trades dated from 11 May 2010 to 19 March 2014.
Every open-market trade on record is a purchase: 1 purchase worth €71k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 21 March 2014 with a transaction (€100k) in Cadence Pharmaceuticals Inc. The most recent open-market purchase was published on 11 May 2010, 6,009 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations